InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-22.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by david auregan, Chief Financial Officer. Officer active across 1 company, notably THERACLION. Aggregated, 2 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €33k. Activity tracked since 1 June 2021. The latest transaction was disclosed on 26 January 2024 (Acquisition). Regulator: AMF. All data is accessible without signup.
Declarations2 total
65,417 shares@ €0.50278.2% of flowActionHors plateforme de négociation2024DD948364
Ideal exit: 22 Oct 2024 (T+270)
11,456 shares@ €0.8021.8% of flowOption d'achatEuronext Growth Paris2021DD758854
2 of 2 declarations
About david auregan
David Auregan is the Chief Financial Officer and Deputy CEO of Theraclion. In this role, he is responsible for the financial management of the company, including financial planning and performance analysis. His expertise in finance is essential for ensuring the profitability and sustainability of Theraclion's operations. He works closely with other executives to support the company's growth strategy.
